Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005786
Status:
TERMINATED
Last Update Posted:
2013-02-01
First Post:
2000-06-02
Brief Title:
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Waldenström Macroglobulinemia |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Prolymphocytic Leukemia |
| Recurrent Adult Diffuse Small Cleaved Cell Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Small Lymphocytic Lymphoma |
| Refractory Chronic Lymphocytic Leukemia |
| Splenic Marginal Zone Lymphoma |
Keywords: